Results 111 to 120 of about 3,367,821 (256)

What is the Incidence of Kidney Stones after Chemotherapy in Patients with Lymphoproliferative or Myeloproliferative Disorders?

International Brazilian Journal of Urology, 2014
Introduction This study describes the incidence and risk factors of de novo nephrolithiasis among patients with lymphoproliferative or myeloproliferative diseases who have undergone chemotherapy. Materials and Methods
Hossein S. Mirheydar, Pooya Banapour, Rustin Massoudi, Kerrin L. Palazzi, Ramzi Jabaji, Erin G. Reid, Frederick E. Millard, Christopher J. Kane, Roger L. Sur   +8 more
doaj   +1 more source

Alzheimer\u27s Disease and Down\u27s Syndrome: An Overview [PDF]

, 2011
The association between Alzheimer\u27s Disease and Down\u27s Syndrome is well recognized through clinical observations and genetic studies. However, the exact nature and the implications of this link is far from clear as yet.
Desai, M.B.B.S., Dr.Devanshu
core   +1 more source

Role of Chitinase 3–like‐1 in Myelofibrosis via Fibroblast‐Produced Extracellular Matrix Enhancement

Journal of Cellular Physiology, Volume 241, Issue 4, April 2026.
Our results indicate the involvement of CHI3L1 in the fibrocyte–fibroblast interaction and exacerbate BM fibrosis by promoting extracellular matrix formation. CHI3L1 is a missing link between fibrocytes and myofibroblasts and is a new potential therapeutic target for MF treatment.
Shoichiro Kato, Toshikuni Kawamura, Takaaki Maekawa, Hiraku Ogata, Noriaki Tachi, Yukiko Osawa, Shinichi Kobayashi   +6 more
wiley   +1 more source

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria

Cancer Medicine, 2020
Philadelphia chromosome‐negative (Ph−) myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal disorders of the bone marrow, and are associated with a high disease burden, reduced quality of life (QOL), and shortened survival.
Mohamed A. Yassin, Ali Taher, Vikram Mathews, Hsin‐An Hou, Tahir Shamsi, Tülin Firatli Tuğlular, Zhijian Xiao, Soo‐Jeong Kim, Wu Depei, Junmin Li, Gerd Rippin, Islam Sadek, Asif Siddiqui, Raymond S. Wong   +13 more
doaj   +1 more source

Eosinophilic fasciitis (Shulman's disease): review and comparative evaluation of seven patients. [PDF]

, 2019
OBJECTIVES: Eosinophilic fasciitis (EF) was described in 1974 by Shulman as a rare fibrosing connective tissue disease of unknown etiology. An undetermined trigger is thought to lead to the degranulation of eosinophils that interact with fibroblasts and
Cimbron, M, Farinha, F, Mendonça, T, Urzal, J   +3 more
core   +1 more source

Noonan Syndrome Presenting With Severe Transient Thrombocytopenia and Hemolytic Anemia in a Neonate With a Germline PTPN11 Pathogenic Variant

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Noonan syndrome (NS) is a RASopathy that can have hematological presentations, most commonly NS‐related myeloproliferative disorder (NS/MPD) and juvenile myelomonocytic leukemia. Other neonatal hematologic presentations remain poorly defined.
Ariel Gershon, Tanvi Anandampillai, Elaine Suk‐Ying Goh, Caroline Malcolmson, Yiming Wang   +4 more
wiley   +1 more source

Myeloproliferative disorders and its associated mutations

Research in Molecular Medicine, 2014
Myeloproliferative Neoplasm (MPN) are a clonal disorder in hematopoietic stem cells (HSC). MPN is categorized to 8 subclasses, including chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocytopenia (ET), primary myelofibrosis (PMF),
Kaveh Tari, Reza Yarahmadi, Amir Tabatabaei, Fakhredin Saba, Saeid Abroun, Amir Atashi, Masoud Soleimani   +6 more
doaj  

To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference [PDF]

Medičnì Perspektivi, 2015
Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm.
Nikolayenko-Kamyshova T.P.
doaj  

Hypereosinophilia: Clinical Presentations and Diagnostic Distinction between Syndromic and Reactive Entities – A Case Series

Romanian Journal of Internal Medicine
Hypereosinophilic syndrome (HES) is a heterogeneous group of disorders characterized by sustained eosinophilia and multi-organ involvement resulting from eosinophil-mediated tissue injury. The condition may arise from diverse etiologies, including clonal
Parrey Ashaq Hussain, Kassana Basharat, Bhat Hilal, Ismail Mohd.   +3 more
doaj   +1 more source

What Is Your Diagnosis? Multiple Subcutaneous Lumps in a Horse

Veterinary Clinical Pathology, EarlyView.
Federica Meistro, Maria Virginia Ralletti, Riccardo Rinnovati, Alessandro Spadari, Maria Morini   +4 more
wiley   +1 more source